Table 1.
Study first author, journal, year of publication | Design of the study | Inclusion criteria | Comparators (number of patients per group) | Main result | Other results |
---|---|---|---|---|---|
El-Solh AA. Eur Respir J 2006 |
Prospective study with historical matching |
Extubation of patients with BMI ≥ 35 kg/m2 in ICU Prophylactic NIV |
124 patients 62 consecutive patients were assigned to NIV via nasal mask immediately post-extubation 62 historically matched controls treated with conventional oxygen therapy |
16% (95% confidence interval 2.9–29.3%) absolute risk reduction in the rate of respiratory failure in the first 48 h post-extubation | Post hoc analysis of the 47 patients who had hypercapnia during a trial of spontaneous breathing: reduced hospital mortality |
Duarte AG. Critical Care Medicine 2007 |
Retrospective study |
Patients with morbid obesity with ARF requiring ventilatory assistance Curative NIV |
50 patients 33 patients treated with NIV, 17 with IMV |
21 avoided intubation (NIV success) and 12 required intubation (NIV failure) |
Significant improvements in pH and Paco2 were noted for the IMV and NIV success groups Hospital mortality for the IMV and NIV failure groups was increased |
Neligan PJ. Anesthesiology 2009 |
Randomized controlled trial |
Patients with morbid obesity and known obstructive sleep apnea undergoing laparoscopic bariatric surgery Prophylactic NIV |
40 patients 20 in the continuous positive airway pressure via the Boussignac system immediately after extubation (Boussignac group) 20 in the supplemental oxygen (standard care group) |
Less reduction in forced vital capacity from baseline to 24 h after extubation in the Boussignac group |
Less reduction in forced expiratory volume in 1 s and peak expiratory flow rate in the Boussignac group |
Zoremba M. BMC anesthesiology 2011 |
Prospective observational study |
Patients with BMI 30–45 kg/m2 undergoing minor peripheral surgery Prophylactic NIV |
60 patients 30 were randomly assigned to receive short-term NIV 30 received routine treatment (supplemental oxygen via Venturi mask) |
During the PACU stay, inspiratory and expiratory lung function in the NIV group was significantly better than in the controls (p < 0.0001) | Blood gases and the alveolar to arterial oxygen partial pressure difference were also better in the NIV group |
Lemyze M. Plos One 2014 |
Prospective observational study |
Patients with BMI > 40 kg/m2 prospectively included diagnosed with OHS and treated by NIV for ARF Curative NIV |
76 patients under NIV | NIV failed to reverse ARF in 13 patients | The patients failing NIV experienced poor outcome despite early resort to endotracheal intubation (in-hospital mortality, 92.3% vs 17.5%; p < 0.001) |
Corley A. Intensive Care Med 2015 |
Randomized controlled trial |
Patients with extubation post-cardiac surgery with a BMI ≥ 30 kg/m2 Prophylactic HFNC |
155 patients 74 in the control group (conventional oxygen therapy) 81 in the HFNC group |
No difference was seen between groups in atelectasis scores on Day 1 or 5 |
In the 24-h post-extubation, there was no difference in mean PaO2/FiO2 ratio or respiratory rate |
Stephan F. Respir Care 2017 |
Post hoc analysis of a randomized controlled trial |
Patients with obesity Extubation after cardiothoracic surgery Prophylactic and curative NIV |
231 patients 136 in the NIV group, 135 in the HFNC group |
Treatment failure (defined as re-intubation, switch to the other treatment, or premature discontinuation) did not significantly differ between groups | No significant differences were found for dyspnea and comfort scores. Skin breakdown was significantly more common with NIV after 24 h |
NIV noninvasive ventilation, ARF acute respiratory failure, BMI body mass index, HFNC high-flow nasal cannula oxygen, OHS obesity hypoventilation syndrome, IMV invasive mechanical ventilation